331
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Research

CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model system

, , , , , , , , & show all
Pages 1315-1325 | Received 17 Dec 2009, Accepted 01 Apr 2010, Published online: 17 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Roba M. Talaat, Amal M. Abdel-Aziz, Eman A. El-Maadawy & Naser Abdel-Bary. (2015) CD38 and Interleukin 6 Gene Polymorphism in Egyptians with Diffuse Large B-Cell Lymphoma (DLBCL). Immunological Investigations 44:3, pages 265-278.
Read now

Articles from other publishers (10)

Sergio Díaz-Fernández, Raquel Villar-Hernández, Zoran Stojanovic, Marco Fernández, Maria Luiza De Souza Galvão, Guillermo Tolosa, Adrián Sánchez-Montalva, Jorge Abad, María Ángeles Jiménez-Fuentes, Guillem Safont, Iris Romero, Josefina Sabrià, Cristina Prat, Jose Domínguez & Irene Latorre. (2022) Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment. Frontiers in Microbiology 13.
Crossref
Claudete M. S. Ferreira, Noemia M. O. Sunada & Jorge Casseb. (2022) T-lymphocyte activation markers in patients with HIV-1-associated neurocognitive disorder. Journal of NeuroVirology 28:3, pages 404-409.
Crossref
Valentina Audrito, Vincenzo Gianluca Messana, Lorenzo Brandimarte & Silvia Deaglio. (2021) The Extracellular NADome Modulates Immune Responses. Frontiers in Immunology 12.
Crossref
Elżbieta Rutkowska, Iwona Kwiecień, Katarzyna Kulik, Beata Chełstowska, Krzysztof Kłos, Piotr Rzepecki & Andrzej Chciałowski. (2021) Usefulness of the New Hematological Parameter: Reactive Lymphocytes RE-LYMP with Flow Cytometry Markers of Inflammation in COVID-19. Cells 10:1, pages 82.
Crossref
Lola E. Navas & Amancio Carnero. (2021) NAD+ metabolism, stemness, the immune response, and cancer. Signal Transduction and Targeted Therapy 6:1.
Crossref
David T. Omstead, Franklin Mejia, Jenna Sjoerdsma, Baksun Kim, Jaeho Shin, Sabrina Khan, Junmin Wu, Tanyel Kiziltepe, Laurie E. Littlepage & Basar Bilgicer. (2020) In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma. Journal of Hematology & Oncology 13:1.
Crossref
Valentina Audrito, Antonella Managò, Federica Gaudino, Leonardo Sorci, Vincenzo Gianluca Messana, Nadia Raffaelli & Silvia Deaglio. (2019) NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer. Frontiers in Immunology 10.
Crossref
Marcos J. Ramos-Benitez, Caleb Ruiz-Jimenez, Jose J. Rosado-Franco, Willy D. Ramos-Pérez, Loyda B. Mendez, Antonio Osuna & Ana M. Espino. (2018) Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock. mSphere 3:6.
Crossref
Claudia C.S. Chini, Anatilde M. Gonzalez Guerrico, Veronica Nin, Juliana Camacho-Pereira, Carlos Escande, Maria Thereza Barbosa & Eduardo N. Chini. (2014) Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors. Clinical Cancer Research 20:1, pages 120-130.
Crossref
Naveen L. Pereira, Pinar Aksoy, Irene Moon, Yi Peng, Margaret M. Redfield, John C. BurnettJr.Jr., Eric D. Wieben, Vivien C. Yee & Richard M. Weinshilboum. (2010) Natriuretic peptide pharmacogenetics: Membrane metallo-endopeptidase (MME): Common gene sequence variation, functional characterization and degradation. Journal of Molecular and Cellular Cardiology 49:5, pages 864-874.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.